+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

The expression of cartilage oligomeric matrix protein, thrombospondin-1, bone sialoprotein and osteopontin in calcified and non-calcified arterial lesions



The expression of cartilage oligomeric matrix protein, thrombospondin-1, bone sialoprotein and osteopontin in calcified and non-calcified arterial lesions



Biochemical Society Transactions 26(1): S3




(PDF emailed within 1 workday: $29.90)

Accession: 047641971

Download citation: RISBibTeXText

PMID: 10909761


Related references

The expression of osteopontin and thrombospondin-1 in calcified and non-calcified arterial lesions. Journal of Pathology 181(SUPPL ): 31A, 1997

Distribution and expression of cartilage oligomeric matrix protein and bone sialoprotein show marked changes during rat femoral head development. Matrix Biology 14(9): 773-781, 1995

Expression of cartilage-specific markers in calcified and non-calcified atherosclerotic lesions. Atherosclerosis 196(1): 37-41, 2007

Calcified rheumatic heart valves are associated with osteopontin bone matrix expression. Journal of the American College of Cardiology 41(6 Supplement A): 500A, March 19, 2003

Expression of three bone matrix proteins, osteonectin, osteopontin and bone sialoprotein in human breast lesions. Breast Cancer Research & Treatment 27(1-2): 186, 1993

Serum concentrations of cartilage oligomeric matrix protein and bone sialoprotein in hip osteoarthritis: a one year prospective study. Annals of the Rheumatic Diseases 57(9): 527-532, 1998

Increased serum levels of cartilage oligomeric matrix protein and bone sialoprotein in rats with collagen arthritis. British Journal of Rheumatology 36(12): 1258-1261, 1998

Cleavage of cartilage oligomeric matrix protein (thrombospondin-5) by matrix metalloproteinases and a disintegrin and metalloproteinase with thrombospondin motifs. Matrix Biology 22(3): 267-278, 2003

Inhibition of interleukin-1alpha-induced cartilage oligomeric matrix protein degradation in bovine articular cartilage by matrix metalloproteinase inhibitors: potential role for matrix metalloproteinases in the generation of cartilage oligomeric matrix protein fragments in arthritic synovial fluid. Arthritis and Rheumatism 41(12): 2143-2151, 1998

Matrix Gla protein (MGP) and bone morphogenetic protein-2 in aortic calcified lesions of aging rats. Journal of Thrombosis and Haemostasis 1(1): 178-185, 2003

Cartilage damage involving extrusion of mineralisable matrix from the articular calcified cartilage and subchondral bone. European Cells and Materials 21: 470-8; Discussion 478, 2011

Cartilage oligomeric matrix protein and thrombospondin: 1. Purification from articular cartilage, electron microscopic structure, and chondrocyte binding. European Journal of Biochemistry 223(3): 927-937, 1994

CD40-CD154 expression in calcified and non-calcified coronary lesions of patients with chronic renal failure. Atherosclerosis 190(1): 156-166, 2006

Interaction of cartilage oligomeric matrix protein/thrombospondin 5 with aggrecan. Journal of Biological Chemistry 282(34): 24591-8, 2007

The lamina limitans of the organic matrix of calcified cartilage and bone. Journal of Ultrastructure Research 38(3): 318-331, 1972